|
(MoneyNewsWire.Net, April 14, 2018 ) According to the report Prostate Cancer, published by Market Data Forecast, the North America market is projected to reach USD 25 billion by 2021, at a CAGR of 8.97% from 2016 to 2021.
Prostate cancer is cancer occuring in the prostate of a man. It is one among the most widespread types of cancer which men face. This cancer usually grows gradually and initially remains restricted to the prostate gland where it might not cause severe harm. This market requires new drugs which will address the unmet needs of low cost and increased survival time.
Get a comprehensive overview of the North America Prostate Cancer: https://www.marketdataforecast.com/market-reports/north-america-prostate-cancer-market-1617/
North America Prostate Cancer: Drivers & Restraints
The market for prostate cancer is rising due to rise in population diagnosed with prostate cancer. Prostate cancer market will also grow by the expected approval of around nine late-stage pipeline products within the forecast period. There has been a lot of growth in the prostate cancer therapeutics market in the past decade via a lot of products targeting advanced forms of this disease and they are showing greatly enhanced efficacy over their predecessors. The side effects associated with treatment of cancer are restraining the growth of market.
Get accurate market forecast and analysis on the North America Prostate Cancer. Request a sample to stay up-to-date on the main trends affecting this market: https://www.marketdataforecast.com/market-reports/north-america-prostate-cancer-market-1617/request-sample
North America Prostate Cancer: Segmentation
By Diagnostic Techniques
· Introduction
· Digital Rectal Exam (DRE)
· Prostate Specific Antigen Test (PSA)
By Surgery
· Introduction
· Radical Prostatectomy
· Orchidectomy
· Trans Urethral Resection (TUR)
By Radiation Therapy
· Introduction
· External Beam Radiation Therapy
o 3D Conformal Radiation Therapy
o Intensity Modulated Radiation Therapy
o Stereotactic Body Radiation Therapy
o Proton Beam Radiation Therapy
· Brachytherapy
o Permanent Brachytherapy
o Temporary Brachytherapy
By Chemotherapy
· Introduction
· Docetaxel
· Etoposide
· Vinblastine
· Carboplatin
· Vinorelbine
From simple data collection through secondary and primary research to ad-hoc research requests relating to specific information, we provide our services via customization. Get customization at: https://www.marketdataforecast.com/market-reports/north-america-prostate-cancer-market-1617/customize-report
North America Prostate Cancer: Overview
Factors like rising incidence of prostate cancer and rising technological advancements is affecting the growth of market positively. However, the key restraint which is faced by this market is the side effects which are associated with the treatment.
North America Prostate Cancer: Region-wise Outlook
The market for Prostate Cancer in North America region is divided based on geography into United States, Canada and Mexico. North America region holds the largest market for prostate cancer in the world by share. In the North America region, United States is expected to hold the largest share.
Key Questions Answered
· What is the current and future Prostate Cancer outlook in North America market? What trends are affecting the North America market?
· What is the competitive landscape and market share of major players in the Prostate Cancer space in North America market?
· What are the key, high growth markets that Prostate Cancer manufacturers should expand into? Which market segments are growing the fastest?
· What are the unmet needs with the Prostate Cancer currently on the market? How will emerging technologies fulfil these unmet needs?
· What is physician perception and market outlook of Prostate Cancer?
· What are the challenges and barriers that have hindered widespread adoption of Prostate Cancer?
North America Prostate Cancer: Key Players
Some of the major companies dominating North America Prostate Cancer Market are Sanofi S.A, GlaxoSmithKline, AstraZeneca, AbbVie, Varian Medical Systems, Elekta, Theragenics, Pfizer, Novartis, Roche, Bayer, Johnson & Johnson, Abbott Laboratories, and Genentech etc. The market registered substantial growth in the recent years, due to the various strategies such as opting for agreements and collaborations, adopted by leading market players.
Order your copy of the report: https://www.marketdataforecast.com/cart/buy-now/north-america-prostate-cancer-market-1617/
About Us:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
Contact:
Abhishek Shukla
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Mail:abhishek@marketdataforecast.com
Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/
Follow us @ https://in.linkedin.com/company/market-data-forecast
Market Data Forecast.
Abhishek Shukla
+1-888-702-9626
abhishek@marketdataforecast.com
Source: EmailWire.Com 
|
